Beaton Management Co. Inc. Has $220,000 Position in The Clorox Company (NYSE:CLX)

Beaton Management Co. Inc. cut its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 66.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,491 shares of the company's stock after selling 3,000 shares during the period. Beaton Management Co. Inc.'s holdings in Clorox were worth $220,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CLX. Y Intercept Hong Kong Ltd bought a new position in shares of Clorox during the fourth quarter valued at $285,000. Proficio Capital Partners LLC acquired a new stake in Clorox in the fourth quarter valued at $9,047,000. QRG Capital Management Inc. raised its position in Clorox by 64.0% during the 4th quarter. QRG Capital Management Inc. now owns 2,266 shares of the company's stock worth $368,000 after purchasing an additional 884 shares during the last quarter. SVB Wealth LLC bought a new stake in shares of Clorox in the 4th quarter valued at about $299,000. Finally, Fisher Asset Management LLC grew its position in shares of Clorox by 1.4% in the 4th quarter. Fisher Asset Management LLC now owns 26,427 shares of the company's stock valued at $4,292,000 after buying an additional 376 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CLX shares. Citigroup lowered their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. UBS Group decreased their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Morgan Stanley lowered their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Barclays reduced their price objective on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research note on Wednesday, May 7th. Finally, Wells Fargo & Company decreased their price objective on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of "Hold" and an average target price of $149.50.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the business's stock in a transaction that occurred on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director directly owned 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.57% of the stock is currently owned by corporate insiders.

Clorox Stock Up 0.8%

Shares of NYSE CLX opened at $120.04 on Tuesday. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The firm has a market cap of $14.79 billion, a PE ratio of 21.55, a P/E/G ratio of 2.70 and a beta of 0.54. The company's fifty day simple moving average is $130.83 and its 200 day simple moving average is $144.69. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 324.23% and a net margin of 9.89%. The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period last year, the company earned $1.71 EPS. Clorox's revenue for the quarter was down 8.0% compared to the same quarter last year. As a group, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.